Taiwan-funded medical firm vows to further tap into Chinese mainland market
STORY: Taiwan-funded medical firm vows to further tap into Chinese mainland market
SHOOTING TIME: File & June 12, 2024
DATELINE: June 14, 2024
LENGTH: 0:01:23
LOCATION: XIAMEN, China
CATEGORY: ECONOMY
SHOTLIST:
1. various of Lihpao Biotechnology Co., Ltd.
2. SOUNDBITE (Chinese): LI MINGHUI, Assistant to the president of Lihpao Biotechnology Co., Ltd.
STORYLINE:
Lihpao Biotechnology Co., Ltd., a Taiwan-invested gene sequencing firm, entered the Chinese mainland market in 2016.
Based in China's eastern coastal city of Xiamen in Fujian Province, the company has grown rapidly due to the favorable business environment and supportive policies.
It has vowed to continue its pace of investing in the health sector in the coming years.
SOUNDBITE (Chinese): LI MINGHUI, Assistant to the president of Lihpao Biotechnology Co., Ltd.
"In the past three years, the company's business in Xiamen has grown exponentially, strengthening our confidence and determination to deeply cultivate the Chinese mainland market. The compa
- Product Code
- ILEA002859877
- Registered date
- 2024/6/14 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 52.28(MB)*
*File size when opened in Photoshop, etc.